DOI: https://doi.org/10.15416/pcpr.v5i3

Table of Contents

Original Article

Anti-malarial Drugs as Potential Inhibitors of Leishmania Glycolytic Enzymes: Development of New Anti-leishmanial Agents
Bashir A. Yousef, Tanzeel H. Elwaseela, Tagwa A. Ali, Fatima E. Mohammed, Wala O. Mohammed, Majdi Alobaid, Amina I. Dirar
PDF
77-88
Antibiotics in Prevention and Treatment of Multi-Drug Resistant (MDR) Organisms causing Surgical Site Infection (SSI)
Saranya K. Lakshmi, Hema N. Gowda, Anuradha Kundapur
PDF
89-97
Medication Adherence to Successful Tuberculosis Treatment Outcome among TB/HIV Patient at Prof. Dr. Sulianti Saroso Infectious Disease Hospital
Yusmaniar Yusmaniar, Adin H Kurniawan
PDF
98-105
Effect of COVID-19 on the Treatment of Infections by Community Pharmacists in Nigeria
Edidiong Orok, Success David, Chiemezie Ibegwam
PDF
106-114
Estimating Atherosclerosis Cardiovascular Disease Risk of 10-year with the Systemic Coronary Risk Estimation Method and Statin Use Recommendation
Nurmainah - Nurmainah, Syarifah N.Y.R.S Asseggaf
PDF
115-121
Authors and Keywords Index
Editorial PCPR
PDF